Determining the commercial potential of the first-in-class small molecule allosteric modulators at the human gastric inhibitory polypeptide receptor

确定首创的人胃抑制多肽受体小分子变构调节剂的商业潜力

• 批准号: BB/S01165X/1
• 负责人: Graham Ladds
• 金额: $ 1.3万
• 依托单位: University of Cambridge
• 依托单位国家: 英国
• 项目类别: Research Grant
• 财政年份: 2018
• 资助国家: 英国
• 起止时间: 2018 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=BB%2FS01165X%2F1
• 关键词: Determining; commercial; potential; first; class

Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.

GTR目前尚未用于所有资助研究的摘要。这通常是因为提交提案时不需要摘要，但可能是因为它包含了敏感信息，例如个人详细信息。